Exenatide; Clinical data; Trade names: Byetta, Bydureon: AHFS/Drugs.com: Monograph: MedlinePlus: a605034: Pregnancy category. INTRODUCTION. Two oral classes of drugs lower blood glucose by modifying the intestinal absorption of carbohydrates and fat: alpha-glucosidase inhibitors and lipase. This topic has 1593 study abstracts on Turmeric indicating that it may have therapeutic value in the treatment of Oxidative Stress, Inflammation, and DNA damage. ![]() A New Class of Diabetes Medications. Sodium- glucose co- transporter 2 (SGLT2) inhibitors are a new class of diabetic medications indicated only for the treatment of type 2 diabetes. In conjunction with exercise and a healthy diet, they can improve glycemic control. They have been studied alone and with other medications including metformin, sulfonylureas, nizagara 1. SGLT2 inhibitors block the reabsorption of glucose in the kidney, increase glucose excretion, and lower blood glucose levels. How they work: SGLT2 is a low- affinity, high capacity glucose transporter located in the proximal tubule in the kidneys. It is responsible for 9. Inhibition of SGLT2 leads to the decrease in blood glucose due to the increase in renal glucose excretion. The mechanism of action of this new class of drugs also offers further glucose control by allowing increased insulin sensitivity and uptake of glucose in the muscle cells, decreased gluconeogenesis and improved first phase insulin release from the beta cells. Traditionally, diet modification has been the cornerstone of diabetes management. Weight loss is more likely to control glycemia in patients with recent onset of the. There are three different tablets in this group. SGLT2 Inhibitors work in the following ways: Reducing the amount of glucose being absorbed in the kidneys so that it. There are a number of different types of diabetes drugs - with some having similar ways of acting. Drugs which act similarly to each other are put into the same class. Comparison of reversible acetylcholinesterase inhibitors; Inhibitor Duration Main site of action Clinical use Adverse effects; Edrophonium: short (10 min. Manufactured by Bayer Corporation, acarbose is available.It is proposed that in prehistoric times, we developed an elegant system for maximizing energy conservation and storage, due to lack of consistent food supplies. This system included reducing the activity of our neurological endocrine system to slow metabolism and conserve the stored energy in our bodies, as well as a method to increase reabsorption of excess glucose that was removed by the kidneys. Now that the majority of our type 2 patients have an adequate or most likely an over- abundant supply of glucose from the foods we eat this system is no longer necessary for survival and in fact contributes to increased weight and diabetes risk. The first of the defects was addressed in May of 2. Cycloset (bromocriptine mesylate rapid release) was approved by the FDA and now with the approval of Invokana (canagliflozin), Jardiance (empagliflozin), and Farxiga (dapagliflozin), we have medications to address the second half of this problem. Drugs in the SGLT2 inhibitors class include empagliflozin, canagliflozin, dapagliflozin, ipragliflozin (which has not yet been approved for use in the U. S.). At this time canagliflozin is the only drug in this class approved by the FDA for the treatment of type 2 diabetes. Vaginal yeast infections and urinary tract infections are the most common side effects associated with canagliflozin with the greatest risk being in female patients and those men who are uncircumcised. There is also an increased desire to urinate and the medication is not indicated in patients with type 1 diabetes, or patients with frequent ketones in their blood or urine, severe renal impairment, end stage renal disease or patients receiving dialysis. Patients should be advised to expect glucose to be in the urine and if they are using urine glucose strips that they will have a positive reading most of the time. See more SGLT- 2 Resources. References: “Canagliflozin Provided Substantial and Sustained Glycemic Improvements as Monotherapy and in Add- On Combinations in Adults with Type 2 Diabetes in Five Phase 3 Studies.” Johnson & Johnson. Jansen Research & Development, 0. June 2. 01. 2. 2. Clarke, Toni. Thomson Reuters, 2. Mar. 2. 01. 3.“Diabetes Treatment, Part 2: Oral Agents for Glycemic Management.” Clinical Diabetes. FDA Approves Invokana to Treat Type 2 Diabetes. Invokana.” INVOKANA. Nainggolan, Lisa. N. p., 2. 9 Mar. 2. Marina Farid, Pharm. D Candidate, FAMU College of Pharmacy also contributed to this article. Nov 2. 7. Epub 2. Nov 2. 7. PMID: 2. Article Published Date : Nov 2. Study Type : Meta Analysis. Apr ; 2. 0(4): 4. Epub 2. 01. 7 May 4. PMID: 2. 84. 70. 85. Article Published Date : Mar 3. Study Type : Meta Analysis, Review. Dec 1. 4. Epub 2. Dec 1. 4. PMID: 2. Article Published Date : Dec 1. Study Type : Meta Analysis, Review. Epub 2. 01. 6 Jul 5. PMID: 2. 73. 92. 74. Article Published Date : Jul 0. Study Type : Meta Analysis. Aug ; 1. 9(8): 7. PMID: 2. 75. 33. 64. Article Published Date : Jul 3. Study Type : Meta Analysis, Review. Mar 2. 6 ; 1. 07: 2. Epub 2. 01. 6 Mar 2. PMID: 2. 70. 25. 78. Article Published Date : Mar 2. Study Type : Meta Analysis. Click here to read the complete article. Pubmed Data : Nutr J. Epub 2. 01. 5 May 1. PMID: 2. 59. 72. 15. Article Published Date : Dec 3. Study Type : Meta Analysis, Review. Click here to read the complete article. Pubmed Data : Eur Rev Med Pharmacol Sci. Nov ; 1. 9(2. 1): 4. PMID: 2. 65. 92. 84. Article Published Date : Oct 3. Study Type : Human Study. Jun; 5. 6(2): 9. 3- 9. PMID: 2. 04. 85. 24. Article Published Date : Jun 0. Study Type : Human Study. Click here to read the complete article. Pubmed Data : J Gastrointestin Liver Dis. Jun ; 2. 5(2): 1. PMID: 2. 73. 08. 64. Article Published Date : May 3. Study Type : Human Study. Jun; 3. 3(6): 5. 49- 5. Epub 2. 00. 9 Jan 3. PMID: 1. 91. 81. 48. Article Published Date : Jun 0. Study Type : Human Study. Dec; 1. 5(4): 3. 37- 4. PMID: 2. 11. 94. 24. Article Published Date : Dec 0. Study Type : Human Study. Click here to read the complete article. Pubmed Data : Open Rheumatol J. Epub 2. 01. 4 Oct 1. PMID: 2. 53. 52. 92. Article Published Date : Dec 3. Study Type : Human Study. Jan; 1. 4(1): 1. 20- 5. PMID: 1. 56. 68. 48. Article Published Date : Jan 0. Study Type : Human Study. Click here to read the complete article. Pubmed Data : Mol Med Rep. Nov ; 8(5): 1. 54. Epub 2. 01. 3 Aug 2. PMID: 2. 40. 02. 21. Article Published Date : Oct 3. Study Type : Human Study. Click here to read the complete article. Pubmed Data : J Clin Diagn Res. Dec ; 8(1. 2): ZC0. Epub 2. 01. 4 Dec 5. PMID: 2. 56. 54. 02. Article Published Date : Nov 3. Study Type : Human Study. PMID: 1. 64. 13. 41. Article Published Date : Jan 0. Study Type : Human Study. Click here to read the complete article. Pubmed Data : Asian Pac J Cancer Prev. PMID: 2. 42. 89. 57. Article Published Date : Dec 3. Study Type : Human Study. Click here to read the complete article. Pubmed Data : Prostate Cancer Prostatic Dis. Mar 1. 1. Epub 2. Mar 1. 1. PMID: 2. Article Published Date : Mar 1. Study Type : Human Study. PMID: 1. 85. 88. 35. Article Published Date : Jan 0. Study Type : Human Study. Click here to read the complete article. Pubmed Data : Oman Med J. Sep ; 2. 9(5): 3. PMID: 2. 53. 37. 30. Article Published Date : Aug 3. Study Type : Human Study. Jun 2. 8. Epub 2. Jun 2. 8. PMID: 2. Article Published Date : Jun 2. Study Type : Human Study. Aug ; 1. 3(8): 1. Epub 2. 01. 5 Feb 2. PMID: 2. 57. 24. 70. Article Published Date : Jul 3. Study Type : Human Study. Jun; 2. 8(3): 2. 77- 8. PMID: 2. 01. 50. 60. Article Published Date : Jun 0. Study Type : Human Study. May; 6. 4(4): 3. 53- 6. PMID: 9. 61. 91. 20. Article Published Date : May 0. Study Type : Human Study. Dec 1. 5; 8. 0(1. PMID: 1. 63. 71. 92. Article Published Date : Dec 1. Study Type : Human Study. May 1. 0. Epub 2. May 1. 0. PMID: 2. Article Published Date : May 0. Study Type : Human Study. Aug 1. 5; 9. 4(8): 4. PMID: 1. 04. 95. 62. Article Published Date : Aug 1. Study Type : Human Study. Aug 1. 4; 1. 4(3. PMID: 1. 87. 20. 53. Article Published Date : Aug 1. Study Type : Human Study. Aug 1. 5. Epub 2. Aug 1. 5. PMID: 2. Article Published Date : Aug 1. Study Type : Human Study. Jan 1. 8. Epub 2. Jan 1. 8. PMID: 2. Article Published Date : Jan 1. Study Type : Human Study. Epub 2. 01. 3 Jul 1. PMID: 2. 38. 28. 32. Article Published Date : Dec 3. Study Type : Human Study. Click here to read the complete article. Pubmed Data : Nutrients. Nov 2. 1 ; 8(1. 1). Epub 2. 01. 6 Nov 2. PMID: 2. 78. 79. 64. Article Published Date : Nov 2. Study Type : Human Study. Jan 1. 9. Epub 2. Jan 1. 9. PMID: 2. Article Published Date : Jan 1. Study Type : Human Study. Click here to read the complete article. Pubmed Data : J Sports Sci Med. Mar ; 1. 6(1): 1. Epub 2. 01. 7 Mar 1. PMID: 2. 83. 44. 46. Article Published Date : Feb 2. Study Type : Human Study. Dec; 4(1. 2): 1. 50. Epub 2. 00. 6 Nov 1. PMID: 1. 71. 01. 30. Article Published Date : Dec 0. Study Type : Human Study. Sep; 1. 0(1): 1- 7. PMID: 1. 69. 88. 47. Article Published Date : Sep 0. Study Type : Human Study. Jun ; 2. 3(3): 3. Epub 2. 01. 5 Apr 9. PMID: 2. 60. 51. 56. Article Published Date : May 3. Study Type : Human Study. Jun; 1. 3(4): 3. 18- 2. PMID: 1. 04. 04. 53. Article Published Date : Jun 0. Study Type : Human Study. Aug ; 3. 5(4): 4. PMID: 2. 60. 66. 33. Article Published Date : Jul 3. Study Type : Human Study. PMID: 2. 05. 87. 94. Article Published Date : Jan 0. Study Type : Human Study. Nov 1. 1. Epub 2. Nov 1. 1. PMID: 2. Article Published Date : Nov 1. Study Type : Human Study. Jan- Feb; 3. 2(1): 6. PMID: 1. 01. 02. 95. Article Published Date : Jan 0. Study Type : Human Study. Click here to read the complete article. Pubmed Data : Photomed Laser Surg. Nov ; 3. 2(1. 1): 6. Epub 2. 01. 4 Oct 2. PMID: 2. 53. 43. 37. Article Published Date : Oct 3. Study Type : Human Study. Dec; 2. 4(1. 2): 6. PMID: 3. 54. 61. 66. Article Published Date : Dec 0. Study Type : Human Study. PMID: 1. 24. 95. 26. Article Published Date : Jan 0. Study Type : Human Study. Mar; 2(1): 1. 61- 3. PMID: 1. 97. 07. 43. Article Published Date : Mar 0. Study Type : Human Study. Jul 1. 5; 1. 4(1. PMID: 1. 86. 28. 46. Article Published Date : Jul 1. Study Type : Human Study. Sep; 1. 4(6): 4. 43- 7. PMID: 1. 09. 60. 89. Article Published Date : Sep 0. Study Type : Human Study. Sep 1. 5; 1. 5(1. Epub 2. 00. 9 Sep 8. PMID: 1. 97. 37. 96. Article Published Date : Sep 1. Study Type : Human Study. Epub 2. 01. 0 Oct 2. PMID: 2. 10. 60. 67. Article Published Date : Jan 0. Study Type : Human Study. Click here to read the complete article. Pubmed Data : J Clin Diagn Res. Aug ; 8(8): HC1. 9- 2. Epub 2. 01. 4 Aug 2. PMID: 2. 53. 02. 21. Article Published Date : Jul 3. Study Type : Human Study. Click here to read the complete article. Pubmed Data : J Oral Maxillofac Pathol. May- Aug; 1. 9(2): 1. PMID: 2. 66. 04. 48. Article Published Date : Apr 3. Study Type : Human Study. Epub 2. 01. 6 Jan 1. PMID: 2. 67. 71. 29. Article Published Date : Dec 3. Study Type : Human Study. Nov; 5. 0(1. 1): 2. PMID: 1. 62. 40. 23. Article Published Date : Nov 0. Study Type : Human Study. Sep; 2. 0(3): 3. 65- 7. PMID: 1. 76. 71. 74. Article Published Date : Sep 0. Study Type : Human Study. Oct 1. 6; 4. 07(1): 5. Epub 2. 00. 6 Sep 1. PMID: 1. 69. 49. 20. Article Published Date : Oct 1. Study Type : Human Study. Oct ; 3. 2(1. 0): 7. Epub 2. 01. 2 Oct 1. PMID: 2. 31. 46. 77. Article Published Date : Sep 3. Study Type : Human Study. Click here to read the complete article. Pubmed Data : Eur J Appl Physiol. Sep ; 1. 15(9): 1. Epub 2. 01. 5 Apr 2. PMID: 2. 59. 21. 60. Article Published Date : Aug 3. Study Type : Human Study. Oct; 5. 4(1. 0): 2. Epub 2. 00. 8 Dec 3. PMID: 1. 90. 51. 01. Article Published Date : Oct 0. Study Type : Human Study. PMID: 2. 35. 07. 68. Article Published Date : Dec 3. Study Type : Human Study. Epub 2. 01. 3 Jul 6. PMID: 2. 38. 32. 43. Article Published Date : Jul 0. Study Type : Human Study. Jul- Aug; 2. 1(4. B): 2. 89. 5- 9. 00. PMID: 1. 17. 12. 78. Article Published Date : Jul 0. Study Type : Human Study. Click here to read the complete article. Pubmed Data : Cochrane Database Syst Rev. CD0. 08. 42. 4. Epub 2. Oct 1. 7. PMID: 2. Article Published Date : Dec 3. Study Type : Human Study. Nov 2. 4. PMID: 2. Article Published Date : Nov 2. Study Type : Human Study. Epub 2. 01. 0 Oct 1. PMID: 2. 09. 37. 16. Article Published Date : Jan 0. Study Type : Human Study. May ; 8. 7(5): 4. Epub 2. 01. 2 Apr 4. PMID: 2. 24. 73. 80. Article Published Date : Apr 3. Study Type : Human Study. Click here to read the complete article. Pubmed Data : J Clin Diagn Res. Aug ; 9(8): ZC5. 9- 6. Epub 2. 01. 5 Aug 1. PMID: 2. 64. 36. 04. Article Published Date : Jul 3. Study Type : Human Study. Click here to read the complete article. Pubmed Data : J Clin Diagn Res. Apr ; 1. 1(4): ZC8. ZC9. 3. Epub 2. 01. Apr 1. PMID: 2. 85. Article Published Date : Mar 3. Study Type : Human Study. Sep ; 5. 3(3 Suppl 1): 4. PMID: 2. 21. 08. 47. Article Published Date : Sep 0. Study Type : Human Study. Feb; 3. 4(1): 3. 7- 4. PMID: 1. 47. 64. 30. Article Published Date : Feb 0. Study Type : Human Study. Click here to read the complete article. Pubmed Data : PLo. S One. 2. 01. 7 ; 1. Epub 2. 01. 7 Mar 3. PMID: 2. 82. 57. 51. Article Published Date : Dec 3. Study Type : Human Study. Epub 2. 01. 0 Jan 7. PMID: 2. 00. 56. 73. Article Published Date : Jan 0. Study Type : Human Study. Mar; 2. 0(2): 1. 23- 3. PMID: 2. 13. 32. 09. Article Published Date : Mar 0. Study Type : Human Study. Aug; 1. 30(8): 2. Epub 2. 01. 0 Apr 1. PMID: 2. 03. 93. 48. Article Published Date : Aug 0. Study Type : Human Study. Nov ; 4. 9(Pt 6): 5. Epub 2. 01. 2 Oct 4. PMID: 2. 30. 38. 70. Article Published Date : Oct 3. Study Type : Human Study. Jan ; 2. 5(1): 3. Epub 2. 01. 4 Dec 5. PMID: 2. 55. 23. 88. Article Published Date : Dec 3. Study Type : Human Study. Jun 6 ; 8. 2: 5. 78- 5. Epub 2. 01. 6 Jun 6. PMID: 2. 74. 70. 39. Article Published Date : Jun 0. Study Type : Human Study. Nov 2: 1- 9. Epub 2. Nov 2. PMID: 1. 98. Article Published Date : Nov 0. Study Type : Human Study. Nov; 1. 43(5): 9. PMID: 1. 10. 69. 50. Article Published Date : Nov 0. Study Type : Human Study. Click here to read the complete article. Pubmed Data : Biomed Res Int. Epub 2. 01. 5 May 1. PMID: 2. 60. 90. 39. Article Published Date : Dec 3. Study Type : Human Study. Epub 2. 01. 4 Jun 1. PMID: 2. 50. 46. 62. Article Published Date : Dec 3. Study Type : Human Study. Apr 2. 3. Epub 2. Apr 2. 3. PMID: 2. Article Published Date : Apr 2. Study Type : Human In Vitro, Human Study. Mar; 4. 3(4- 5): 4. Epub 2. 00. 9 Nov 1. PMID: 1. 99. 00. 43. Article Published Date : Mar 0. Study Type : Human Study. Jul 1 ; 1. 10(1): 4. Epub 2. 01. 2 Apr 3. PMID: 2. 24. 81. 01. Article Published Date : Jun 3.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
November 2017
Categories |